Nova Eye Medical LtdASX: EYE

Half year results discussion

· Issued by Nova Eye Medical Ltd

Filed with ASX · · 5 pages · English

® Nova Eye Medical Limited (ASX: EYE) (Nova Eye Medical or the Company), a medical technology company committed to advanced ophthalmic treatment technologies and devices, today announces the half-year financial results for the six months ended 31 December 2022. Glaucoma Surgical Devices Segment Nova Eye Medical reported group revenues of $6.54 million, attributable almost entirely to the sale of i

Nova Eye Medical Ltd on 6ix

In the deck

Story so far

Earlier from Nova Eye Medical

Later from Nova Eye Medical

All Nova Eye Medical news releases